← Leaderboards
Konrad Hochedlinger
Massachusetts General Hospital
$15,714,725
Attributed
$15,714,725
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.6M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,714,725 · 7
By mechanism
R01$10,489,349 · 4
DP2$2,625,000 · 1
P01$2,227,077 · 1
R21$373,299 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Michael Mannstadt$4,555,232
- Frederick M Ausubel$22,351,893
- Cammie Lesser$16,591,943
- Sekar Kathiresan$50,580,753
- Max Jan$1,188,918
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsCell TypeMolecularIn VivoInsightPatternEpigenetic ProcessPhenotypeGenesReportingIn VitroPluripotencySignal TransductionGeneticStem CellsInduced Pluripotent Stem CellTranscription FactorAdultGenetic TranscriptionExhibitsGenerationsPlayProgenitorMaintenance
Grant awards (32)
Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotency$511,569
R01 · FY2025 · HD · contact PI
Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotency$506,454
R01 · FY2024 · HD · contact PI
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors$422,958
R01 · FY2024 · AR · contact PI
Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotency$511,569
R01 · FY2023 · HD · contact PI
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors$436,039
R01 · FY2023 · AR · contact PI
Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotency$511,569
R01 · FY2022 · HD · contact PI
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors$431,678
R01 · FY2022 · AR · contact PI
Dissecting mechanistic links between MAPK signaling, genomic hypomethylation and naive pluripotency$511,569
R01 · FY2021 · HD · contact PI
Roles of sumoylation and alternative polyadenylation in cellular reprogramming$456,939
P01 · FY2021 · GM · contact PI
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors$422,957
R01 · FY2021 · AR · contact PI
Roles of sumoylation and alternative polyadenylation in cellular reprogramming$451,449
P01 · FY2020 · GM · contact PI
Investigating the direct reprogramming of fibroblasts into skeletal muscle progenitors$450,999
R01 · FY2020 · AR · contact PI
Transcription Factor Induced Reprogramming$562,327
R01 · FY2019 · HD · contact PI
Roles of sumoylation and alternative polyadenylation in cellular reprogramming$446,252
P01 · FY2019 · GM · contact PI
Transcription Factor Induced Reprogramming$562,327
R01 · FY2018 · HD · contact PI
Roles of sumoylation and alternative polyadenylation in cellular reprogramming$441,332
P01 · FY2018 · GM · contact PI
Transcription Factor Induced Reprogramming$562,327
R01 · FY2017 · HD · contact PI
Roles of sumoylation and alternative polyadenylation in cellular reprogramming$431,105
P01 · FY2017 · GM · contact PI
Dissecting the molecular and functional role of Sox2 in synovial sarcoma$166,664
R21 · FY2017 · CA · contact PI
Transcription Factor Induced Reprogramming$556,704
R01 · FY2016 · HD · contact PI
Dissecting the molecular and functional role of Sox2 in synovial sarcoma$206,635
R21 · FY2016 · CA · contact PI
Transcription Factor Induced Reprogramming$562,327
R01 · FY2015 · HD · contact PI
Role of Sox2 in stomach development, regeneration and cancer$352,698
R01 · FY2015 · DK · contact PI
Role of Sox2 in stomach development, regeneration and cancer$352,698
R01 · FY2014 · DK · contact PI
Transcription Factor Induced Reprogramming$306,930
R01 · FY2014 · HD · contact PI
Role of Sox2 in stomach development, regeneration and cancer$340,354
R01 · FY2013 · DK · contact PI
Transcription Factor Induced Reprogramming$299,668
R01 · FY2013 · HD · contact PI
Role of Sox2 in stomach development, regeneration and cancer$353,155
R01 · FY2012 · DK · contact PI
Transcription Factor Induced Reprogramming$315,772
R01 · FY2012 · HD · contact PI
Transcription Factor Induced Reprogramming$315,772
R01 · FY2011 · HD · contact PI
Transcription Factor Induced Reprogramming$328,929
R01 · FY2010 · HD · contact PI
Reprogramming of somatic cells by defined factors$2,625,000
DP2 · FY2007 · OD · contact PI